Patient was double vaccinated and double boosted. Caught covid from under 5 granddaughter, tested positive. Started Paxlovid, full course. Tested negative; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Patient was double vaccinated and double boosted. Caught covid from under 5 granddaughter, tested positive. Started Paxlovid, full course. Tested negative) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19 treatment.    Concurrent medical conditions included Allergy NOS.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-May-2022, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On 17-May-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (Patient was double vaccinated and double boosted. Caught covid from under 5 granddaughter, tested positive. Started Paxlovid, full course. Tested negative). At the time of the report, COVID-19 (Patient was double vaccinated and double boosted. Caught covid from under 5 granddaughter, tested positive. Started Paxlovid, full course. Tested negative) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Caught COVID from under 5 granddaughter, tested positive., negative (Negative) Started Paxlovid, full course. Tested negative per protocol six days later and positive (Positive) Four days after that, runny nose began and tested COVID positive..         Patient had allergic reaction to unspecified drug. Concomitant medication was not reported. The patient was not taking any other medications/products within 2 weeks of starting COVID-19 treatment. The patient had previously received a COVID-19 Vaccine. Seems to be Paxlovid Rebound. Device Date : 18-May-2022 Company Comment: This spontaneous case concerns a male patient with no age reported, with no relevant medical history reported, who experienced Non-serious , unexpected. AESI of Covid 19 which occurred 21  days post vaccination with the 4th dose of mRNA-1273 vaccine . This patient's dose 1, 2, and dose 3 of Covid 19 vaccine were  also   mRNA -1273 vaccines . It was reported that this patient caught Covid from her under 5 granddaughter, tested positive and  started  NIRMATRELVIR, RITONAVIR  ( Paxlovid)  on 6-05-2022 , full course at an unspecified dose and frequency,  a  Co-suspect product , non-company product. He tested negative per protocol  of the Paxlovid six days later. However four days after that, runny nose began and tested Covid positive(  Paxlovid Rebound ) .  Other details of the event were  not reported including other treatment medications, results of other laboratories/diagnostic procedures . There was no report if any medical consult was done.  Outcome of the event was reported as resolving. The benefit -risk relationship of mRNA -1273 ( Moderna Covid 19 Vaccine) is not affected by this report.; Sender's Comments: This spontaneous case concerns a male patient with no age reported, with no relevant medical history reported, who experienced Non-serious , unexpected. AESI of Covid 19 which occurred 21  days post vaccination with the 4th dose of mRNA-1273 vaccine . This patient's dose 1, 2, and dose 3 of Covid 19 vaccine were  also   mRNA -1273 vaccines . It was reported that this patient caught Covid from her under 5 granddaughter, tested positive and  started  NIRMATRELVIR, RITONAVIR  ( Paxlovid)  on 6-05-2022 , full course at an unspecified dose and frequency,  a  Co-suspect product , non-company product. He tested negative per protocol  of the Paxlovid six days later. However four days after that, runny nose began and tested Covid positive(  Paxlovid Rebound ) .  Other details of the event were  not reported including other treatment medications, results of other laboratories/diagnostic procedures . There was no report if any medical consult was done.  Outcome of the event was reported as resolving. The benefit -risk relationship of mRNA -1273 ( Moderna Covid 19 Vaccine) is not affected by this report.